Ad Code: Vyvgart - Display Banners Conference - 230758

Findings of a recent post-hoc analysis, which was presented at PNS 2025, demonstrated the efficacy of a gene therapy in reducing the severity and progression of peripheral neuropathy.

The Peripheral Nerve Society annual meeting highlighted Charcot-Marie Tooth Disease (CMT). Specific CMT topics included gene therapy, aging with CMT, and more.

The annual Peripheral Nerve Society meeting will include a series of mini-symposia on Charcot-Marie-Tooth Disease, peripheral nerve repair, and more.

Forthcoming highlights of the annual meeting of the Peripheral Nerve Society include eight special lectures, including the closing keynote.